Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 1

Clinical treatment options for patients with homonymous visual field defects

Authors Alison R Lane, Daniel T Smith, Thomas Schenk

Published Date March 2008 Volume 2008:2(1) Pages 93—102

DOI http://dx.doi.org/10.2147/OPTH.S2371

Published 17 March 2008

Alison R Lane, Daniel T Smith, Thomas Schenk

Cognitive Neuroscience Research Unit, Durham University, Durham, UK

Abstract: The objective of this review is to evaluate treatments for homonymous visual field defects (HVFDs). We distinguish between three treatments: visual restoration training (VRT), optical aids, and compensatory training. VRT is both the most ambitious and controversial approach, aiming to restore portions of the lost visual field. While early studies suggested that VRT can reduce the visual field defect, recent studies using more reliable means of monitoring the patients’ fixation could not confirm this effect. Studies utilizing modern optical aids have reported some promising results, but the extent to which these aids can reliably reduce the patients’ visual disability has yet to be confirmed. Compensatory approaches, which teach patients more effective ways of using their eyes, are currently the only form of treatment for which behavioral improvements have been demonstrated. However, with the exception of one study using a reading training, placebo-controlled clinical evaluation studies are lacking. It is also not yet clear whether the training benefits found in laboratory tasks lead to reliable improvements in activities of daily living and which of the various forms of compensatory training is the most promising. It is therefore too early to recommend any of the currently available treatment approaches.

Keywords: homonymous hemianopia, rehabilitation, treatment outcome

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Intravenous magnetic nanoparticle cancer hyperthermia

Huang HS, Hainfeld JF

International Journal of Nanomedicine 2013, 8:2521-2532

Published Date: 17 July 2013

Effects of home telemonitoring on transitions between frailty states and death for older adults: a randomized controlled trial

Upatising B, Hanson GJ, Kim YL, Cha SS, Yih Y, Takahashi PY

International Journal of General Medicine 2013, 6:145-151

Published Date: 14 March 2013

Fat embolism due to bilateral femoral fracture: a case report

Porpodis K, Karanikas M, Zarogoulidis P, Konoglou M, Domvri K, Mitrakas A, Boglou P, Bakali S, Iordanidis A, Zervas V, Courcoutsakis N, Katsikogiannis N, Zarogoulidis K

International Journal of General Medicine 2012, 5:59-63

Published Date: 16 January 2012

Double motion of upper eyelids in Graves’ orbitopathy: an additional sign for detection of thyroid dysfunction or positive thyroid autoantibodies

Hirohiko Kakizaki, Yasuhiro Takahashi, Masayoshi Iwaki, et al

Clinical Ophthalmology 2011, 5:327-330

Published Date: 3 March 2011

Clarifying the mechanism of idiopathic macular hole development in fellow eyes using spectral-domain optical coherence tomography

Mikiko Takezawa, Fumihiko Toyoda, Chiho Kambara, et al

Clinical Ophthalmology 2011, 5:101-108

Published Date: 20 January 2011

Observation of posterior corneal vesicles with in vivo confocal microscopy and anterior segment OCT

Ryou Watanabe, Toru Nakazawa, Nobuo Fuse

Clinical Ophthalmology 2010, 4:1243-1247

Published Date: 27 October 2010

Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis

Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, et al

International Journal of Nanomedicine 2010, 5:525-532

Published Date: 15 September 2010

Atomic force microscopy probing in the measurement of cell mechanics

Dimitrios Kirmizis, Stergios Logothetidis

International Journal of Nanomedicine 2010, 5:137-145

Published Date: 23 March 2010